IP Library Granted Patent US 9,850,285
Granted Patent B2
US 9,850,285 · App. 14/842,332 · Granted Dec 26, 2017

Process for preparing eptifibatide

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,850,285
App. No.
14/842,332
Granted
Dec 26, 2017
Kind
B2
Abstract

The present invention provides processes for preparation of eptifibatide that involve coupling of amino acids in a (2+5), (4+3) and (3+4) sequence method. The invention further provides products produced by the described processes, novel compounds that can be used as synthetic intermediates for the preparation of eptifibatide.

Claims (18)

1. A process for preparation of eptifibatide of Formula I (SEQ ID NO:1):

wherein Mpr is mercaptopropionic acid, Har is homoarginyl, Gly is glycyl, Asp is aspartyl, Trp is tryptophanyl, Pro is prolyl, and Cys-NH 2 is cysteinamide, the process comprising the steps of:

a) coupling Cys(P 5 )—NH 2 and Trp(P 4 )-Pro-OH to obtain a peptide fragment of formula Trp(P 4 )-Pro-Cys(P 5 )—NH 2 ;

b) coupling the peptide fragment of formula Trp(P 4 )-Pro-Cys(P 5 )—NH 2 and Asp(P 3 )—OH to obtain a peptide fragment of formula Asp(P 3 )-Trp(P 4 )-Pro-Cys(P 5 )—NH 2 (SEQ ID NO:5);

c) coupling the peptide fragment of formula Asp(P 3 )-Trp(P 4 )—Pro-Cys(P 5 )—NH 2 (SEQ ID NO:5) and Gly-OH to obtain a peptide fragment of formula Gly-Asp(P 3 )-Trp(P 4 )-Pro-Cys(P 5 )—NH 2 (SEQ ID NO:6);

d) purifying the peptide fragment of formula Gly-Asp(P 3 )-Trp(P 4 )-Pro-Cys(P 5 )—NH 2 (SEQ ID NO:6) produced in step c) to less than 0.1% Gly-Asp(P 3 )-Trp(P 4 )-Pro-Cys(P 5 )(D)-NH 2 (SEQ ID NO:7), Gly-Asp(P 3 )(D)-Trp(P 4 )-Pro-Cys(P 5 )—NH 2 (SEQ ID NO:8), Gly-Asp(P 3 )-Trp(P 4 )(D)-Pro-Cys(P 5 )—NH 2 (SEQ ID NO:9), or Gly-Asp(P 3 )-Trp(P 4 )-Pro(D)-Cys(P 5 )—NH 2 (SEQ ID NO:10) by HPLC;

e) coupling the peptide fragment of formula Gly-Asp(P 3 )-Trp(P 4 )-Pro-Cys(P 5 )—NH 2 (SEQ ID NO:6) and a 1-2 peptide fragment of formula Mpr(P 1 )-Har(P 2 )—OH to obtain protected linear peptide of formula Mpr(P 1 )-Har(P 2 )-Gly-Asp(P 3 )-Trp(P 4 )-Pro-Cys(P 5 )—NH 2 (SEQ NO:3);

f) optionally purifying Mpr(P 1 )-Har(P 2 )-Gly-Asp(P 3 )-Trp(P 4 )-Pro-Cys(P 5 )—NH 2 (SEQ NO:3);

g) deprotection of the Mpr(P 1 )-Har(P 2 )-Gly-Asp(P 3 )-Trp(P 4 )-Pro-Cys(P 5 )—NH 2 (SEQ NO:3) to obtain linear peptide of formula Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH 2 (SEQ ID NO:4); and

h) cyclizing the two sulphur atoms of the Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH 2 (SEQ ID NO:4) to obtain eptifibatide of Formula I (SEQ ID NO:1),

wherein each one of P 1 and P 5 is one of hydrogen and a sulphur protecting group, each one of P 2 and P 4 is one of hydrogen and an amino protecting group, and P 3 is one of hydrogen and a carboxyl protecting group.

2. The process of claim 1 , wherein the coupling is carried out with a suitable coupling agent selected from the group consisting of HOBT, HOAT, DCC, EDC, CDI, ethyl 2-cyano-2-(hydroxyimino)acetate, and mixtures thereof.

3. The process of claim 1 , wherein the step g) is carried out with a suitable deprotecting agent selected from the group consisting of trifluoroacetic acid, hydrobromic acid, acetic acid, and hydrogen fluoride; and

wherein the step h) is carried out in the presence of atmospheric air, oxygen gas or hydrogen peroxide.

4. The process of claim 1 further comprising the step of subjecting the eptifibatide obtained from step h) to a flash chromatography system using an eluent to obtain pure eptifibatide.

5. The method of claim 4 , wherein the eluent is selected from the group consisting of alcohols, nitrile solvents, water, acids, and mixtures thereof.

6. The method of claim 4 , wherein the eluent is selected from the group consisting of methanol, ethanol, isopropanol, acetonitrile, propionitrile, acetic acid, trifluoro acetic acid, water, and mixtures thereof.

7. The method of claim 4 , wherein the pure eptifibatide has a purity of at least 99%.

Assignments (2)
CHANGE OF NAME Recorded Aug 11, 2017
From: LAURUS LABS PRIVATE LIMITED
To: LAURUS LABS LIMITED
Reel/Frame 043538/0192 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2015
From: VELAYUDHAN, SUBHA NAIR; BOLLU, RAVINDRA BABU; INDUKURI, VENKATA S.; GORANTLA, SEETA R.; KALLAM, VENKATA S.; MADIVADA, BALA M.
To: LAURUS LABS PRIVATE LTD.
Reel/Frame 036474/0785 →